Prostanoid-mediated contractions of the carotid artery become Nox2-independent with aging

Age

Volumn 37, Issue 4, 2015, Pages

  Meyer, Matthias R ^a,b   Fredette, Natalie C ^a   Barton, Matthias ^c   Prossnitz, Eric R ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Aging; Carotid artery; NADPH oxidase; Nox2; Prostanoid; Superoxide

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PROSTANOID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TEMPOL; AMINE OXIDE; ANTIOXIDANT; CYBB PROTEIN, MOUSE; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDRAZINE DERIVATIVE; MEMBRANE PROTEIN; MESSENGER RNA; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPIN LABEL; THROMBOXANE RECEPTOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AREA UNDER THE CURVE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE;

ACETYLCHOLINE; AGING; ANIMALS; ANTIOXIDANTS; CAROTID ARTERIES; CYCLIC N-OXIDES; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HYDRAZINES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; RECEPTORS, THROMBOXANE; RNA, MESSENGER; SPIN LABELS; TISSUE CULTURE TECHNIQUES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84938392411     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-015-9806-9     Document Type: Article

References (46)

1. Barton M (2014) Aging and endothelin: determinants of disease. Life Sci 118:97–109
2. Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Luscher TF (1997) Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 30:817–824
3. Brandes RP, Weissmann N, Schroder K (2010) NADPH oxidases in cardiovascular disease. Free Radic Biol Med 49:687–706
4. Cosentino F, Sill JC, Katusic ZS (1994) Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension 23:229–235
5. Crauwels HM, Van Hove CE, Herman AG, Bult H (2000) Heterogeneity in relaxation mechanisms in the carotid and the femoral artery of the mouse. Eur J Pharmacol 404:341–351
6. Csanyi G, Cifuentes-Pagano E, Al Ghouleh I, Ranayhossaini DJ, Egana L, Lopes LR, Jackson HM, Kelley EE, Pagano PJ (2011) Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic Biol Med 51:1116–1125
7. Dalager S, Paaske WP, Kristensen IB, Laurberg JM, Falk E (2007) Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke 38:2698–2705
8. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97–E102
9. Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, Seals DR (2007) Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100:1659–1666
10. Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453–471
11. Durrant JR, Seals DR, Connell ML, Russell MJ, Lawson BR, Folian BJ, Donato AJ, Lesniewski LA (2009) Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. J Physiol 587:3271–3285
12. Feletou M, Vanhoutte PM (2006) Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291:H985–H1002
13. Fleenor BS, Seals DR, Zigler ML, Sindler AL (2012) Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell 11:269–276
14. Gao YJ, Lee RM (2005) Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 146:1061–1068
15. Gerland P, Raftery AE, Sevcikova H, Li N, Gu D, Spoorenberg T, Alkema L, Fosdick BK, Chunn J, Lalic N, Bay G, Buettner T, Heilig GK, Wilmoth J (2014) World population stabilization unlikely this century. Science 346:234–237
16. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42:2672–2713
17. Hahn NE, Musters RJ, Fritz JM, Pagano PJ, Vonk AB, Paulus WJ, van Rossum AC, Meischl C, Niessen HW, Krijnen PA (2014) Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells. Cell Signal 26:1818–1824
18. Heymes C, Habib A, Yang D, Mathieu E, Marotte F, Samuel J, Boulanger CM (2000) Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br J Pharmacol 131:804–810
19. Huisman A, Van De Wiel A, Rabelink TJ, Van Faassen EE (2004) Wine polyphenols and ethanol do not significantly scavenge superoxide nor affect endothelial nitric oxide production. J Nutr Biochem 15:426–432
20. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, Drummond GR (2010) Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol 298:H24–H32
21. Katusic ZS, Schugel J, Cosentino F, Vanhoutte PM (1993) Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol 264:H859–H864
22. Kretz M, Mundy AL, Widmer CC, Barton M (2006) Early aging and anatomic heterogeneity determine cyclooxygenase-mediated vasoconstriction to angiotensin II in mice. J Cardiovasc Pharmacol 48:30–33
23. Lassegue B, San Martin A, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:1364–1390
24. Ling X, Cota-Gomez A, Flores NC, Hernandez-Saavedra D, McCord JM, Marecki JC, Haskins K, McDuffie M, Powers K, Kench J, Oka M, McMurtry I, Flores SC (2005) Alterations in redox homeostasis and prostaglandins impair endothelial-dependent vasodilation in euglycemic autoimmune nonobese diabetic mice. Free Radic Biol Med 39:1089–1098
25. Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82–C97
26. Meyer MR, Fredette NC, Barton M, Prossnitz ER (2013) Regulation of vascular smooth muscle tone by adipose-derived contracting factor. PLoS One 8, e79245
27. Meyer MR, Barton M, Prossnitz ER (2014a) Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging. Life Sci 118:226–231
28. Meyer MR, Fredette N, Barton M, Prossnitz ER (2014b) Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries. Life Sci 118:213–218
29. Modrick ML, Kinzenbaw DA, Chu Y, Sigmund CD, Faraci FM (2012) Peroxisome proliferator-activated receptor-gamma protects against vascular aging. Am J Physiol Regul Integr Comp Physiol 302:R1184–R1190
30. Mukai Y, Shimokawa H, Higashi M, Morikawa K, Matoba T, Hiroki J, Kunihiro I, Talukder HM, Takeshita A (2002) Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler Thromb Vasc Biol 22:1445–1450
31. Novella S, Dantas AP, Segarra G, Novensa L, Heras M, Hermenegildo C, Medina P (2013) Aging enhances contraction to thromboxane A2 in aorta from female senescence-accelerated mice. Age (Dordr) 35:117–128
32. Oudot A, Martin C, Busseuil D, Vergely C, Demaison L, Rochette L (2006) NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med 40:2214–2222
33. Pereira AC, Olivon VC, de Oliveira AM (2010) An apparent paradox: attenuation of phenylephrine-mediated calcium mobilization and hyperreactivity to phenylephrine in contralateral carotid after balloon injury. J Cardiovasc Pharmacol 56:162–170
34. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ (2001) Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89:408–414
35. Seals DR, Jablonski KL, Donato AJ (2011) Aging and vascular endothelial function in humans. Clin Sci (Lond) 120:357–375
36. Shi Y, Man RY, Vanhoutte PM (2008) Two isoforms of cyclooxygenase contribute to augmented endothelium-dependent contractions in femoral arteries of 1-year-old rats. Acta Pharmacol Sin 29:185–192
37. Solberg LA, Eggen DA (1971) Localization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation 43:711–724
38. Tang EH, Leung FP, Huang Y, Feletou M, So KF, Man RY, Vanhoutte PM (2007) Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 151:15–23
39. Traupe T, Lang M, Goettsch W, Munter K, Morawietz H, Vetter W, Barton M (2002) Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20:2239–2245
40. Vanhoutte PM (2013) One or two, does it matter as long as the arterial wall is coxygenated? Hypertension 62:244–246
41. Wang G, Sarkar P, Peterson JR, Anrather J, Pierce JP, Moore JM, Feng J, Zhou P, Milner TA, Pickel VM, Iadecola C, Davisson RL (2013) COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin II-induced formation of reactive oxygen species and Ca(2+) influx in the subfornical organ. Am J Physiol Heart Circ Physiol 305:H1451–H1461
42. Wong SL, Leung FP, Lau CW, Au CL, Yung LM, Yao X, Chen ZY, Vanhoutte PM, Gollasch M, Huang Y (2009) Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res 104:228–235
43. Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, Vanhoutte PM (2002) Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 136:104–110
44. Zhang M, Song P, Xu J, Zou MH (2011) Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 31:125–132
45. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL (2005) Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289:H1027–H1032
46. Zieman SJ, Melenovsky V, Kass DA (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25:932–943